SCHEMBL14429045

SCHEMBL14429045

CC1(C)O[C@H]2[C@H](n3cnc4c(N)ncnc43)O[C@H](CO[Si](C)(C)C(C)(C)C)CC[C@H]2O1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PI4KA P42356 1/20 0.54
PI4K2B Q8TCG2 1/20 0.54
PI4K2A Q9BTU6 1/20 0.54
PI4KB Q9UBF8 1/20 0.54
RXFP1 Q9HBX9 1/20 0.52
P2RX3 P56373 3/20 0.50
P2RX1 P51575 2/20 0.50
P2RX4 Q99571 2/20 0.50
AMD1 P17707 2/20 0.47
PRMT5 O14744 1/20 0.43
WDR77 Q9BQA1 1/20 0.43
GAA P10253 1/20 0.41
ADORA1 P30542 3/20 0.41
PDE4D Q08499 2/20 0.40
PDE3A Q14432 2/20 0.40
DNPH1 O43598 1/20 0.40
PRKAB2 O43741 1/20 0.40
TRPM2 O94759 1/20 0.40
LDHA P00338 1/20 0.40
ADRB2 P07550 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14429043 0.84 PI4KA (0.58) PI4KAPI4K2BPI4K2API4KBRXFP1
SCHEMBL21377709 0.84 PI4KA (0.70) PI4KAPI4K2BPI4K2API4KBRXFP1
SCHEMBL25756742 0.84 PI4KA (0.70) PI4KAPI4K2BPI4K2API4KBRXFP1
SCHEMBL30546911 0.84 PI4KA (0.70) PI4KAPI4K2BPI4K2API4KBRXFP1
SCHEMBL2291014 0.84 PI4KA (0.70) PI4KAPI4K2BPI4K2API4KBRXFP1
SCHEMBL24146635 0.84 PI4KA (0.70) PI4KAPI4K2BPI4K2API4KBRXFP1
SCHEMBL25756772 0.84 PI4KA (0.70) PI4KAPI4K2BPI4K2API4KBRXFP1
SCHEMBL14429052 0.81 AHCY (0.52) PI4KAPI4K2BPI4K2API4KBAMD1
SCHEMBL12154782 0.80 AHCY (0.47) PI4KAPI4K2BPI4K2API4KBRXFP1
SCHEMBL14429051 0.79 ADORA1 (0.49) PI4KAPI4K2BPI4K2API4KBPRMT5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070185063-A1 Seven-membered ring nucleosides IDENIX PHARMACEUTICALS, INC. 2007-08-09 US disclosed
US-20070185063-A1 Seven-membered ring nucleosides IDENIX PHARMACEUTICALS, INC. 2007-08-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070185063-A1 Seven-membered ring nucleosides NSUN2, NSUN3, HAVCR2 PI4KA 1438/4885PI4K2B 1989/4885PI4K2A 1926/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.